Neurodegenerative Disease Research, Inc. v. Northwestern University

CourtDistrict Court, N.D. Illinois
DecidedNovember 13, 2025
Docket1:25-cv-02775
StatusUnknown

This text of Neurodegenerative Disease Research, Inc. v. Northwestern University (Neurodegenerative Disease Research, Inc. v. Northwestern University) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Neurodegenerative Disease Research, Inc. v. Northwestern University, (N.D. Ill. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

NEURODEGENERATIVE DISEASE RESEARCH, INC.,

Plaintiff, Case No. 25-CV-02775

v. Judge Mary M. Rowland

NORTHWESTERN UNIVERSITY,

Defendant.

MEMORANDUM OPINION AND ORDER Plaintiff Neurodegenerative Disease Research, Inc. (“NDR”) has sued Northwestern University (“Northwestern”), bringing counts for fraudulent concealment, breach of contract, and equitable accounting. Before the Court now is Northwestern’s motion to dismiss [21] the amended complaint [17]. For the reasons stated herein, Northwestern’s motion to dismiss [21] is granted in part and denied in part. I. Background The following factual allegations taken from the operative complaint [17] are accepted as true for the purposes of the motion to dismiss. See Lax v. Mayorkas, 20 F.4th 1178, 1181 (7th Cir. 2021). NDR is a 501(c)(3) nonprofit organization headquartered in Florida. [17] ¶ 1. Dr. Ellison, the president of NDR, founded the organization in March 2020 with the purpose of funding research into amyotrophic lateral sclerosis (“ALS”). [17] ¶¶ 5-11. Dr. Ellison founded NDR after her friend Richard was diagnosed with ALS; Richard had substantial monetary resources and directed NDR to use those resources to fund ALS research. See [17] ¶¶ 8-9. While searching for potential scientists to donate to, Dr. Ellison became aware of

Dr. Siddique, a physician-scientist and neurogeneticist internationally recognized as a preeminent expert in the study of ALS. [17] ¶¶ 12-13. At the time, Dr. Siddique was employed by Northwestern’s Feinberg School of Medicine (“Feinberg”) and had worked for Northwestern since 1991. [17] ¶ 14. Over the next several months, Dr. Ellison and Dr. Siddique discussed various avenues for ALS research, and Dr. Ellison concluded that Dr. Siddique’s proposed research was promising. [17] ¶¶ 15-17. Around January 2021, Dr. Ellison met with Andrew Christopherson, an assistant

dean at Feinberg, who praised Dr. Siddique and emphasized the valuable research that Dr. Siddique’s laboratory produced at Northwestern. [17] ¶ 19. Around this time, Dr. Siddique recommended that NDR make a gift to Northwestern to be designated for funding the ALS research that Dr. Siddique was conducting, and NDR agreed. [17] ¶ 20. Based on her conversations with Dr. Siddique and Mr. Christopherson, Dr. Ellison was under the impression that Dr. Siddique

would direct the projects funded by NDR. [17] ¶ 22. On April 6, 2021, NDR and Northwestern executed their first gift agreement (the “First Agreement”). [17] ¶ 23. The purpose of the First Agreement was for NDR to provide Dr. Siddique and Northwestern with funding to carry out two different ALS research projects. [17] ¶ 23. As a part of the agreement, NDR agreed to donate $1,610,000, and Northwestern agreed to (among other things) prepare an annual report about the use of donations until the donated funds were fully expended. [17] ¶¶ 25-27. After executing the First Agreement, NDR and Dr. Siddique discussed a larger

additional research project, which the parties came to call the “Big Project.” [17] ¶ 28. Dr. Ellison and Dr. Siddique repeatedly discussed the Big Project as a long-term, five- year enterprise. [17] ¶ 30. NDR (and its funder, Richard) communicated to Dr. Siddique that they wanted to fund the Big Project, but that they wanted to do so through incremental, annual donations rather than a lump-sum at the onset. [17] ¶¶ 31-36. The parties ultimate signed a second gift agreement (the “Second Agreement”), which provided that NDR would donate $12.5 million to Northwestern via

semiannual payments of $1.25 million over five years. [17] ¶ 44. Like the First Agreement, the Second Agreement also required Northwestern to prepare an annual report about the use of the donation. [17] ¶ 46. During the negotiations leading up to the Second Agreement, both Northwestern and Dr. Siddique represented that Dr. Siddique and/or his laboratory at Northwestern would be conducting the research funded by the Second Agreement.

See [17] ¶¶ 38 – 41. A draft version of the Second Agreement proposed by Northwestern included language that the donations would be used to “study [ALS] in the laboratory of Dr. Teepu Siddique, or its successor.” [17] ¶ 41. NDR required that the final text be changed to read that donations would “be used to study [ALS] in the laboratory of Dr. Teepu Siddique and under his direction.” [17] ¶ 41. Near the end of 2022, however, Dr. Siddique revealed to NDR that he was leaving Northwestern, and his position with the university was terminated as of February 1, 2023. [17] ¶¶ 61-62. NDR subsequently learned that Dr. Siddique’s and

Northwestern’s relationship had been strained since at least as early as 2019, when Dr. Siddique filed a lawsuit (the “Siddique Action”) against Northwestern. [17] ¶¶ 54- 55. In the Siddique Action, Dr. Siddique alleged, among other things, that Northwestern leadership announced to Feinberg faculty and staff that Dr. Siddique had been “put out to pasture,” that Northwestern leadership was actively looking to replace Dr. Siddique, and that Northwestern leadership was attempting to force Dr.

Siddique out of his role. [17] ¶¶ 56-67. Dr. Siddique and Northwestern entered into a settlement agreement in the Siddique Action in February 2022. [17] ¶ 61. Ultimately, NDR alleges that through both the First and Second Agreements, NDR made payments to Northwestern totaling $3.36 million. [17] ¶ 63. NDR further alleges that Northwestern never provided an annual report as both agreements required, and NDR does not know how its donations were spent. [17] ¶ 65. Further,

NDR alleges that no material progress on ALS research resulted from NDR’s donation, and Dr. Siddique’s departure from Northwestern effectively doomed the Big Project. [17] ¶ 67. II. Standard “To survive a motion to dismiss under Rule 12(b)(6), the complaint must provide enough factual information to state a claim to relief that is plausible on its face and raise a right to relief above the speculative level.” Haywood v. Massage Envy Franchising, LLC, 887 F.3d 329, 333 (7th Cir. 2018) (quoting Camasta v. Jos. A. Bank Clothiers, Inc., 761 F.3d 732, 736 (7th Cir. 2014)); see also Fed. R. Civ. P. 8(a)(2)

(requiring a complaint to contain a “short and plain statement of the claim showing that the pleader is entitled to relief”). A court deciding a Rule 12(b)(6) motion “construe[s] the complaint in the light most favorable to the plaintiff, accept[s] all well-pleaded facts as true, and draw[s] all reasonable inferences in the plaintiff’s favor.” Lax, 20 F.4th at 1181. However, the court need not accept as true “statements of law or unsupported conclusory factual allegations.” Id. (quoting Bilek v. Fed. Ins. Co., 8 F.4th 581, 586 (7th Cir. 2021)). “While detailed factual allegations are not

necessary to survive a motion to dismiss, [the standard] does require ‘more than mere labels and conclusions or a formulaic recitation of the elements of a cause of action to be considered adequate.’” Sevugan v. Direct Energy Servs., LLC, 931 F.3d 610, 614 (7th Cir. 2019) (quoting Bell v. City of Chicago, 835 F.3d 736, 738 (7th Cir. 2016)). Dismissal for failure to state a claim is proper “when the allegations in a complaint, however true, could not raise a claim of entitlement to relief.” Bell Atl.

Corp. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Brewster McCauley v. City of Chicag
671 F.3d 611 (Seventh Circuit, 2011)
Wigod v. Wells Fargo Bank, N.A.
673 F.3d 547 (Seventh Circuit, 2012)
Stogner v. Com. of Ky.
638 F. Supp. 1 (W.D. Kentucky, 1985)
Schilling v. Stahl
918 N.E.2d 1077 (Appellate Court of Illinois, 2009)
Ransom v. A.B. Dick Co.
682 N.E.2d 314 (Appellate Court of Illinois, 1997)
Pearson v. Garrett-Evangelical Theological Seminary, Inc.
790 F. Supp. 2d 759 (N.D. Illinois, 2011)
Connick v. Suzuki Motor Co., Ltd.
675 N.E.2d 584 (Illinois Supreme Court, 1996)
Mann v. Kemper Financial Companies, Inc.
618 N.E.2d 317 (Appellate Court of Illinois, 1992)
Harlem Algonquin LLC v. Canadian Funding Corp.
742 F. Supp. 2d 957 (N.D. Illinois, 2010)
Patrick Camasta v. Jos. A. Bank Clothiers, Inc.
761 F.3d 732 (Seventh Circuit, 2014)
Kathy Haywood v. Massage Envy Franchising, LLC
887 F.3d 329 (Seventh Circuit, 2018)
Chetty Sevugan v. Direct Energy Services, LLC
931 F.3d 610 (Seventh Circuit, 2019)
Isabella Nartey v. Franciscan Health Hospital
2 F.4th 1020 (Seventh Circuit, 2021)
Christopher Bilek v. Federal Insurance Company
8 F.4th 581 (Seventh Circuit, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
Neurodegenerative Disease Research, Inc. v. Northwestern University, Counsel Stack Legal Research, https://law.counselstack.com/opinion/neurodegenerative-disease-research-inc-v-northwestern-university-ilnd-2025.